全部成果分类

按条件检索“325”条记录

已选条件: 核心收录: SCIE ×
导出
  • 排序
  • 显示
5. Correlation between Programmed Death-1 Ligand-1 and p53 in Patients with Lung Adenocarcinoma PubMed SCIE SCOPUS

作者:Xu, C; Zhang, ZH

作者机构:[Xu, Cheng; Zhang, Zhi-Hong] Nanjing Med Univ, Affiliated Hosp 1, Dept Pathol, Nanjing 210029, Jiangsu, Peoples R China.

来源:CHINESE MEDICAL JOURNAL,2018,Vol.131,Issue.8

ESI学科:CLINICAL MEDICINE

最新一期影响因子:1.064

资源类型:外文期刊论文

17. Three-year Follow-up on the Safety and Effectiveness of Rituximab Plus Chemotherapy as First-Line Treatment of Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in Real-World Clinical Settings in China: A Prospective, Multicenter, Noninterventional Study PubMed SCIE SCOPUS

作者:Wu, JQ; Song, YP; Su, LP; Zhang, MZ; Lis, W; Hu, Y; Zhang, XH; Gao, YH; Niu, ZX; Feng, R; Wang, W; Peng, JW; Li, XL; Ouyang, XN; Wu, CP; Zhang, WJ; Zeng, Y; Xiao, Z; Liang, YM; Zhuang, YZ; Wang, JS; Sun, ZM; Bai, H; Cui, TJ; Feng, JF

作者机构:[Wu, Jian-Qiu; Feng, Ji-Feng] Jiangsu Canc Hosp, Dept Oncol, Nanjing 210008, Jiangsu, Peoples R China.; [Wu, Jian-Qiu; Feng, Ji-Feng] Jiangsu Inst Can 更多

关键词:Asian; Hematopoietic Malignancy; Hepatitis B Virus; Observational Study; Rituximab

来源:CHINESE MEDICAL JOURNAL,2018,Vol.131,Issue.15

ESI学科:CLINICAL MEDICINE

最新一期影响因子:1.064

资源类型:外文期刊论文

共 17 页, 325 条记录

TOP